We are live on ! Find out more
ALNA

Allena Pharmaceuticals
ALNA

Delisted

ALNA was delisted on the 7th of September, 2022.

Back to rankings

40 hedge funds and large institutions have $158M invested in Allena Pharmaceuticals in 2017 Q4 according to their latest regulatory filings, with 40 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
40
Holders Change
+40
Holders Change %
–
% of All Funds
0.91%
Holding in Top 10
5
Holding in Top 10 Change
+5
Holding in Top 10 Change %
% of All Funds
0.11%
New
40
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
FM
Frazier Management
Washington
+$41M
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$32.4M
3
DVC
Deer VII & Co
New York
+$27.9M
4
PHS
PFM Health Sciences
California
+$18M
5
PI
Pharmstandard International
Luxembourg
+$12.8M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
AIG
26
American International Group
New York
$37K +$44.7K +3,630 New
Wells Fargo
27
Wells Fargo
California
$27K +$33.2K +2,695 New
TRCT
28
Tower Research Capital (TRC)
New York
$22K +$27.5K +2,232 New
UBS Group
29
UBS Group
Switzerland
$20K +$24.3K +1,974 New
SO
30
STRS Ohio
Ohio
$15K +$18.5K +1,500 New
BNP Paribas Financial Markets
31
BNP Paribas Financial Markets
France
$10.5K +$12.8K +1,040 New
PI
32
Pharmstandard International
Luxembourg
$10.4K +$12.8M +1,037,267 New
Manulife (Manufacturers Life Insurance)
33
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$10K +$12.4K +1,008 New
Barclays
34
Barclays
United Kingdom
$9K +$10.5K +854 New
Legal & General Group
35
Legal & General Group
United Kingdom
$9K +$11.3K +918 New
Parallax Volatility Advisers
36
Parallax Volatility Advisers
California
$8K +$10.4K +840 New
Bank of America
37
Bank of America
North Carolina
$7K +$8.47K +687 New
Citigroup
38
Citigroup
New York
$6K +$7.49K +608 New
AIP
39
Ameritas Investment Partners
Nebraska
$5K +$5.67K +460 New
CCA
40
Catalyst Capital Advisors
New York
$4K +$5.18K +420 New
1
2

ALNA Hedge Fund Activity: Q4 2017 in Review

40 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Allena Pharmaceuticals (ALNA) for Q4 2017, worth a combined $158M.

Buyers outnumbered sellers: 40 funds opened new ALNA positions and 0 closed out — a net gain of 40 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Frazier Management, opening a new position worth an estimated $41M.

  • 40 institutional investors held Allena Pharmaceuticals (ALNA) as of Q4 2017, up from 0 in Q3 2017.
  • Funds reported $158M of Allena Pharmaceuticals stock for Q4 2017.
  • 40 funds opened new Allena Pharmaceuticals positions in Q4 2017 and 0 closed out, a net change of +40 holders.
  • The largest Allena Pharmaceuticals buyer in Q4 2017 was Frazier Management, an estimated $41M added.

Based on aggregated 13F filings for Q4 2017.